CA Patent

CA2622722C — Lysine salts of 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives with improved solubility

Assigned to Janssen Pharmaceutica NV · Expires 2016-04-19 · 10y expired

What this patent protects

The present invention is directed to a novel lysine salts, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by PPAR delta. The present invention is further directed to a novel process for the preparation of said lysi…

USPTO Abstract

The present invention is directed to a novel lysine salts, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by PPAR delta. The present invention is further directed to a novel process for the preparation of said lysine salts.

Drugs covered by this patent

Patent Metadata

Patent number
CA2622722C
Jurisdiction
CA
Classification
—
Expires
2016-04-19
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.